SCHEDULE 13G

 

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

Under the Securities Exchange Act of 1934
(Amendment No. )*

 

Immatics N.V.

(Name of Issuer)

 

Ordinary Shares, nominal value £0.01 per share

(Title of Class of Securities)

 

N44445109

 

 

(CUSIP Number)

 

December 31, 2021

 

 

 

 

(Date of Event which Requires Filing of this Statement)

 

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

x Rule 13d-1(b)

 

¨     Rule 13d-1(c)

 

¨     Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

 CUSIP No.  N44445109 

 

 

 

NAMES OF REPORTING PERSONS

Baker Bros. Advisors LP 

 

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ¨

(b) ¨

 

 

 

 

SEC USE ONLY

 

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware 

       

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

 

 

 

SOLE VOTING POWER
4,423,731 

 

 

SHARED VOTING POWER
-0- 

 

 

SOLE DISPOSITIVE POWER
4,423,731 

 

 

SHARED DISPOSITIVE POWER
-0- 

 

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,423,731 

 

10 

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                             ¨

(See Instructions)

 

 

11 

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.0% (1) 

 

12 

 

TYPE OF REPORTING PERSON (See Instructions)
IA, PN

 

(1)Based on 62,909,231 Ordinary Shares (“Ordinary Shares”) of Immatics N.V. (the “Issuer”) outstanding as of June 30, 2021, as reported in the Issuer’s Form F-3 filed with the Securities and Exchange Commission (“SEC”) on August 2, 2021.

  

 

 

 

CUSIP No.  N44445109 

 

 

 

NAMES OF REPORTING PERSONS

Baker Bros. Advisors (GP) LLC 

 

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ¨

(b) ¨

 

 

 

 

SEC USE ONLY

 

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware 

       

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

 

 

 

SOLE VOTING POWER
4,423,731 

 

 

SHARED VOTING POWER
-0- 

 

 

SOLE DISPOSITIVE POWER
4,423,731 

 

 

SHARED DISPOSITIVE POWER
-0- 

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,423,731 

 

10 

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                               ¨

(See Instructions)

 

 

11 

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.0% (1) 

 

12 

 

TYPE OF REPORTING PERSON (See Instructions)
HC, OO

 

(1)Based on 62,909,231 Ordinary Shares of the Issuer outstanding as of June 30, 2021, as reported in the Issuer’s Form F-3 filed with the SEC on August 2, 2021.

 

 

 

 

CUSIP No.  N44445109

 

 

 

NAMES OF REPORTING PERSONS

Felix J. Baker 

 

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ¨

(b) ¨

 

 

 

 

SEC USE ONLY

 

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION
United States 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

 

 

 

SOLE VOTING POWER
4,423,731

 

 

SHARED VOTING POWER

-0- 

 

 

SOLE DISPOSITIVE POWER
4,423,731 

 

 

SHARED DISPOSITIVE POWER
-0- 

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,423,731 

 

10

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                                 ¨

(See Instructions)

 

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.0% (1) 

 

12

 

TYPE OF REPORTING PERSON (See Instructions)
IN, HC

       
(1)Based on 62,909,231 Ordinary Shares of the Issuer outstanding as of June 30, 2021, as reported in the Issuer’s Form F-3 filed with the SEC on August 2, 2021.

 

 

 

  

CUSIP No.  N44445109

 

 

 

NAMES OF REPORTING PERSONS  


Julian C. Baker 

 

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ¨

(b) ¨

 

 

 

SEC USE ONLY

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION
United States

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

 

 

 

SOLE VOTING POWER
4,423,731 

 

 

SHARED VOTING POWER
-0- 

 

 

SOLE DISPOSITIVE POWER
4,423,731 

 

 

SHARED DISPOSITIVE POWER
-0- 

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,423,731 

 

10

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                                 ¨

(See Instructions)

 

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.0% (1) 

 

12 

 

TYPE OF REPORTING PERSON (See Instructions)
IN, HC

     

(1)Based on 62,909,231 Ordinary Shares of the Issuer outstanding as of June 30, 2021, as reported in the Issuer’s Form F-3 filed with the SEC on August 2, 2021.

  

 

 

 

Schedule 13G 

 

Item 1(a)Name of Issuer:

 

Immatics N.V. (the “Issuer”)

 

Item 1(b)Address of Issuer’s Principal Executive Offices:

 

Paul-Ehrlich-Straße 15

 

72076 Tübingen, Federal Republic of Germany

 

Item 2(a)Name of Person Filing:

 

This Schedule 13G is being filed jointly by Baker Bros. Advisors LP (the “Adviser”), Baker Bros. Advisors (GP) LLC (the “Adviser GP”), Felix J. Baker and Julian C. Baker (collectively, the “Reporting Persons”).

 

Item 2(b)Address of Principal Business Office or, if None, Residence:

 

The business address of each of the Reporting Persons is:

 

c/o Baker Bros. Advisors LP

 

860 Washington Street, 3rd Floor

 

New York, NY 10014

 

(212) 339-5690

 

Item 2(c)Citizenship:

 

The Adviser is a limited partnership organized under the laws of the State of Delaware. The Adviser GP is a limited liability company organized under the laws of the State of Delaware. The citizenship of each of Julian C. Baker and Felix J. Baker is the United States of America.

 

Item 2(d)Title of Class of Securities

 

Ordinary Shares, nominal value £0.01 per share (“Ordinary Shares”).

 

Item 2(e)CUSIP Number

 

N44445109

 

 

 

 

Item 3.If this statement is filed pursuant to §§240.13d-1(b) or (c), check whether the person filing is a:

 

(a) ¨ Broker or dealer registered under Section 15 of the Exchange Act.

 

(b) ¨ Bank as defined in section 3(a)(6) of the Exchange Act.

 

(c) ¨ Insurance company as defined in section 3(a)(19) of the Exchange Act.

 

(d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940.

 

(e) x An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

 

(f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).

 

(g) x A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).

 

(h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.

 

(i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940.

 

(j) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

 

Item 4. Ownership.

 

Items 5 through 9 and 11 of each of the cover pages to this Schedule 13G are incorporated herein reference.

 

Set forth below is the aggregate number of Ordinary Shares directly held by each of Baker Brothers Life Sciences, L.P. (“Life Sciences”) and 667, L.P. (“667”, and together with Life Sciences, the “Funds”) which may be deemed to be indirectly beneficially owned by the Reporting Persons.

 

The information set forth below is based on 62,909,231 Ordinary Shares outstanding as of June 30, 2021, as reported in the Issuer’s Form F-3 filed with the Securities and Exchange Commission on August 2, 2021. Such percentage figures are calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

 

 

 

Name  Number of Ordinary Shares we own or have the right to acquire within 60 days   Percent of Class Outstanding 
667, L.P.   326,301    0.5%
Baker Brothers Life Sciences, L.P.   4,097,430    6.5%
Total   4,423,731    7.0%

 

Pursuant to the management agreements, as amended, among the Adviser, the Funds and their respective general partners, the Funds’ respective general partners relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held by the Funds and thus the Adviser has complete and unlimited discretion and authority with respect to the Funds’ investments and voting power over investments.

 

The Adviser GP, Felix J. Baker and Julian C. Baker as managing members of the Adviser GP, and the Adviser may be deemed to be beneficial owners of securities of the Issuer directly held by the Funds.

 

Item 5.Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨. N/A

 

Item 6.Ownership of More than Five Percent on Behalf of Another Person.

 

N/A

 

Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

The information in Item 4 is incorporated herein by reference.

 

Item 8.Identification and Classification of Members of the Group.

 

N/A

 

Item 9.Notice of Dissolution of Group.

 

N/A

 

 

 

 

Item 10.Certification.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

February 14, 2022

 

 

 

BAKER BROS. ADVISORS LP

 

By: Baker Bros. Advisors (GP) LLC, its general partner 

     
  By: /s/ Scott L. Lessing
    Name: Scott L. Lessing
Title: President

 

  BAKER BROS. ADVISORS (GP) LLC
     
  By: /s/ Scott L. Lessing
    Name: Scott L. Lessing
Title: President
     
     
  /s/ Julian C. Baker
  Julian C. Baker
     
  /s/ Felix J. Baker
  Felix J. Baker

 

 

EXHIBIT 99.1 

 

AGREEMENT

 

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G (including additional amendments thereto) relating to the Ordinary Shares of Immatics N.V. is being filed with the Securities and Exchange Commission on behalf of each of them.

 

February 14, 2022

 

 

BAKER BROS. ADVISORS LP

 

By: Baker Bros. Advisors (GP) LLC, its general partner 

     
  By: /s/ Scott L. Lessing
    Name: Scott L. Lessing
Title: President

 

  BAKER BROS. ADVISORS (GP) LLC
     
  By: /s/ Scott L. Lessing
    Name: Scott L. Lessing
Title: President
     
  /s/ Julian C. Baker
  Julian C. Baker
     
  /s/ Felix J. Baker
  Felix J. Baker